Although the pharmaceutical industry has experienced unparalleled growth recently, there are lots of emerging trends that could challenge this. And one of these simple factors may be the development of emerging markets for example India, South america, Russia and China, to mention a couple of. With economic growth rates reaching double digit percentages in a few of these countries, there’s without doubt they’re major players within the global marketplace for the future. That’s the reason it is no wonder this recent economic growth isn’t just catching the interest of key financial players around the globe, but catching the interest of multinational drug companies too.
Because the global pharmaceutical industry keeps growing, some key trends are showing this growth could soon decrease. Many pharmaceutical talking to firms have experienced these trends coming for along time. Trends like losing marketing exclusivity, in addition to lower contributions from newer products, combined with the growing prevalence of generic drugs around the globe, the worldwide pharmaceutical marketplace might be facing a cruel reality. Many pharmaceutical talking to firms are recognizing this trend, and therefore are visiting a pharmaceutical industry later on, that’s quite different from the among the last half a century.
There’s without doubt the pharmaceutical landscape for the future is going to be vastly not the same as the main one we all know today. For instance, in 1999, prior to the turn from the century, the very best leading pharmaceutical markets on the planet were the U . s . States, Japan, and Europe, comprising nearly 75% from the development in the worldwide pharmaceutical marketplace. Now compare that to today, where these major markets only take into account nearly 45% from the global pharmaceutical rate of growth, whereas the emerging markets have leaped from 8% to almost 30% within this same period. Which trend is just suspected to develop.